SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System

Overview of attention for article published in Diabetologia, May 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

policy: 1 policy source
twitter: 92 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 191 Dimensions

Readers on

mendeley: 190 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

ABCD, 25 Jul 2017

SGLT2i-associated DKA may not be limited to any particular demographic or comorbid subpopulation. 1.54% Mortality